🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate the safety and efficacy of abir...
Status
Completed
Location
Multiple Locations
Start Date
2012-06
Trial ID
NCT01795703
Treatments Being Tested
This study is to evaluate the safety, and preliminary antitumor activity of...
Status
Not Yet Recruiting
Location
Zhejiang Cancer Hospital
Start Date
2025-08
Trial ID
NCT07104617
The purpose of this study is to investigate safety and efficacy of abirater...
Status
Completed
Location
Multiple Locations
Start Date
2012-06-06
Trial ID
NCT01756638
Treatments Being Tested
Single-arm, single site, open label study of the effects of parenteral test...
Status
Completed
Location
Sibley Memorial Hospital
Start Date
2014-08-25
Trial ID
NCT02090114
Treatments Being Tested
This study is comparing the effectiveness of enzalutamide with or without a...
Status
Completed
Location
Johns Hopkins University
Start Date
2014-10
Trial ID
NCT02268175
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of pembroliz...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2016-11-17
Trial ID
NCT02861573
The addition of abiraterone acetate to standard treatment of radiotherapy a...
Status
Completed
Location
Durham Regional Hospital
Start Date
2014-01-17
Trial ID
NCT01717053
Treatments Being Tested
This study is an open label, single arm, multicenter clinical trial. The ai...
Status
Recruiting
Location
The First Affiliated Hospital of China Medical University
Start Date
2024-11-27
Trial ID
NCT06971211
The purpose of this study is to assess the anti-tumor activities and safety...
Status
Completed
Location
Multiple Locations
Start Date
2006-11
Trial ID
NCT00474383
Treatments Being Tested
This is an open label, phase II trial in subjects with treatment naïve, met...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-10
Trial ID
NCT06392841